These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 14150264)
1. [MAMMARY DYSPLASIAS: MEDICAL TREATMENT]. PASI PL Rev Asoc Med Argent; 1964 Mar; 78():120-3. PubMed ID: 14150264 [No Abstract] [Full Text] [Related]
2. [OUR EXPERIENCE IN THE TREATMENT OF FUNCTIONAL METRORRHAGIAS]. OTTURI JE Sem Med; 1963 Jul; 123():124-8. PubMed ID: 14084469 [No Abstract] [Full Text] [Related]
4. MECHANISMS AND THERAPY OF HEPATIC EDEMA. FUCHS M Biochem Clin; 1964; 3():129-38. PubMed ID: 14270154 [No Abstract] [Full Text] [Related]
5. ENDOCRINE TREATMENT OF BREAST CANCER. NISSEN-MEYER R Acta Unio Int Contra Cancrum; 1964; 20():531-4. PubMed ID: 14151981 [No Abstract] [Full Text] [Related]
6. AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion. Marques-Neto SR; Ferraz EB; Rodrigues DC; Njaine B; Rondinelli E; Campos de Carvalho AC; Nascimento JH Cardiovasc Drugs Ther; 2014 Apr; 28(2):125-35. PubMed ID: 24258356 [TBL] [Abstract][Full Text] [Related]
7. [THE TREATMENT OF DYSFUNCTIONAL METRORRHAGIAS OF ADOLESCENCE]. ARRIGHI LA; MENDIZABAL AF; USUBIAGA IS Sem Med; 1963 Nov; 123():1461-3. PubMed ID: 14112723 [No Abstract] [Full Text] [Related]
9. Clinical trial of delautin in the treatment of advanced mammary carcinoma in postmenopausal women. CROWLEY LG; MACDONALD I Cancer; 1962; 15():1218-20. PubMed ID: 14024037 [No Abstract] [Full Text] [Related]
10. Medical management of mammary dysplasia. London RS; Sundaram GS; Goldstein PJ Obstet Gynecol; 1982 Apr; 59(4):519-23. PubMed ID: 7043344 [TBL] [Abstract][Full Text] [Related]
11. Dienogest and the breast. Schindler AE; Henkel A; Christensen B; Oettel M; Moore C Gynecol Endocrinol; 2009 Jul; 25(7):472-4. PubMed ID: 19499407 [TBL] [Abstract][Full Text] [Related]
12. [APPLICATION OF ANTI-ALDOSTERONE DIURETICS TO THE TREATMENT OF LOCALIZED EDEMA OF THE EXTREMITIES IN CANCER PATIENTS]. ABBES M; CAMBON P; PAILLAUD F Presse Med (1893); 1965 May; 73():1285-6. PubMed ID: 14273213 [No Abstract] [Full Text] [Related]
14. Fibrocystic disease: a continuing enigma. Bartow SA; Black WC; Waeckerlin RW; Mettler FA Pathol Annu; 1982; 17 Pt 2():93-111. PubMed ID: 7182760 [No Abstract] [Full Text] [Related]
15. Progestin therapy of breast cancer: comparison of agents. Stoll BA Br Med J; 1967 Aug; 3(5561):338-41. PubMed ID: 6029163 [No Abstract] [Full Text] [Related]
16. [MAMMARY DYSPLASIAS: GENERAL CONCEPTS AND PHYSIOPATHOLOGY]. URIBURU JV Rev Asoc Med Argent; 1964 Mar; 78():111-5. PubMed ID: 14150262 [No Abstract] [Full Text] [Related]
18. The estriol quotient in fibrocystic disease, a high-risk group for breast cancer. Bagli NP; Shah PN; Mistry SS Indian J Cancer; 1980 Dec; 17(4):201-4. PubMed ID: 7228103 [No Abstract] [Full Text] [Related]
19. [ALDOSTERONE ANTAGONISTS IN THE TREATMENT OF CIRRHOTIC ASCITIS]. GARCIA-RAMOSARRIAGA J Acta Med Tenerife; 1963; 20():101-4. PubMed ID: 14093724 [No Abstract] [Full Text] [Related]
20. [Clinical use of concurrent antagonists of aldosterone in patients with cardiac insufficiency]. Smolenskiĭ VS; Gel'fond MB; Khodzhamirov VS; Samosiuk IM Kardiologiia; 1969 Jun; 9(6):13-9. PubMed ID: 5806633 [No Abstract] [Full Text] [Related] [Next] [New Search]